HOME    
 Ufficio Stampa | Mappa del sito | Come raggiungerci | Contatti

Ricerca>Aree e Dipartimenti>Fisiopatologia Digestiva
(i dati si riferiscono al 2005)

Responsabile:M. Cicala
Componenti:R. Caviglia, S. Emerenziani, M.P.L. Guarino


ARTICOLI CON IMPACT FACTOR

Guarino MP, Carotti S, Sarzano M, Alloni R, Vanni M, Grosso M, Sironi G, Maffettone PL, Cicala M.
Short-term ursodeoxycholic acid treatment improves gallbladder bile turnover in gallstone patients: a randomized trial.
Neurogastroenterol Motil. 2005 Oct;17(5):680-6. IF 2.549

Vespasiani Gentilucci U, Caviglia R, Picardi A, Carotti S, Ribolsi M, Galati G, Petitti T, Afeltra A, Cicala M.
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease.
Aliment Pharmacol Ther. 2005 May 1;21(9):1063-71. Erratum in: Aliment Pharmacol Ther. 2005 Jun 1;21(11):1398. IF 3.981

Caviglia R, Ribolsi M, Maggiano N, Gabbrielli AM, Emerenziani S, Guarino MP, Carotti S, Habib FI, Rabitti C, Cicala M.
Dilated intercellular spaces of esophageal epithelium in nonerosive reflux disease patients with physiological esophageal acid exposure.
Am J Gastroenterol. 2005 Mar;100(3):543-8. IF 4.716

Cicala M, Gabbrielli A, Emerenziani S, Guarino MP, Ribolsi M, Caviglia R, Costamagna G.
Effect of endoscopic augmentation of the lower oesophageal sphincter (Gatekeeper reflux repair system) on intraoesophageal dynamic characteristics of acid reflux.
Gut. 2005 Feb;54(2):183-6. IF 6.601

ATTI DI CONGRESSO

Caviglia R, Carotti S, Vespasiani Gentilucci U, Picardi A, Ribolsi M, Afeltra A, Cicala M.
Anti-tumor necrosis factor alpha reverts growth hormone resistance associated with inflammatory bowel disease.
XI National Congress of Digestive Diseases. Genova, 12-16 marzo 2005.
Dig Liver Dis 2005; 37(S1): S140.



Via Álvaro del Portillo, 21 - 00128 Roma - Tel. (+39) 06.22541.1 - Fax (+39) 06.22541.456